Showing 118 of 118on this page. Filters & sort apply to loaded results; URL updates for sharing.118 of 118 on this page
BioLineRx Announces FDA Approval of APHEXDA™ (motixafortide) in Combination
BioLineRX Ltd.: BioLineRx Announces FDA Approval of APHEXDA ...
BioLineRx initiates Phase 2 first-line metastatic pancreatic cancer ...
BioLineRx & Ayrmid Ink Exclusive License Agreement to Commercialize ...
BLRX | BioLineRx Announces Encouraging Data from Pilot Phase of Phase 2 ...
BioLineRx Ltd. (BLRX) Stock Price, Quote, News & Analysis | Seeking Alpha
BioLineRx on LinkedIn: #bioeurope
BioLineRx today announced the initiation of a randomized, investigator ...
BL-8020 exclusive License Agreement with BioLineRx – Genoscience Pharma
BioLineRx Announces New Positive Results In Phase 2a Trial For Orally ...
Biolinerx hi-res stock photography and images - Alamy
BioLineRx | Discover Our Pipeline
BioLineRx Announces New Positive Results in Phase 2a trial for Orally ...
BioLineRx Sees Surge: Time to Invest?
BioLineRx | Discover Careers
BioLineRx (BLRX)’s APHEXDA Captures 10% Market Share in U.S. CXCR4 ...
BioLineRx reveals FDA approval for APHEXDA™ (motixafortide) to ...
BioLineRx Unveils Poster Presentation on Economic Model Data for ...
BioLineRx | Driving innovative therapeutics across the finish line
BioLineRx (BLRX) Stock Price & Overview
BioLineRx Announces Publication of Pre-clinical Results Demonstrating ...
BioLineRx & GenFleet Co-Development — MSQ
BioLineRx Announces First Patient Dosed in Phase 1 Clinical Trial ...
BioLineRx Ltd. (BLRX) BCG Matrix Analysis – DCFmodeling.com
BioLineRx on LinkedIn: We are proud to announce collaboration agreement ...
BioLineRx (BLRX) Stock Price, News & Analysis
BioLineRx | LinkedIn
BioLineRx doses first subject in Phase II pancreatic cancer trial
Israel’s BioLineRx progresses in clinical trials of treatment relevant ...
BioLineRx lance « Mobilization Matters » : Une ressource numérique pour ...
BioLineRx | Partner with Us
BioLineRx ($BLRX) is excited to announce strengthening of its ...
BioLineRx Stock: On a Path to Growth?
BioLineRx doses first subject with motixafortide in SCD trial
BioLineRx concludes enrolment in intratumoural cancer vaccine trial
BioLineRx Reports Q3 2025 Results and Strategic Expansion
BioLineRx Ltd. (BLRX) Stock Price, News, Quote & History - Yahoo Finance
#biolinerx #meetourteam #clinicaloperations | BioLineRx
BioLineRx Soars 10.1% on Pipeline Progress
BioLineRx to Report 2024 Annual Results on March 31, 2025 ...
BioLineRx Ltd. (BLRX): Business Model Canvas – DCFmodeling.com
Today is Apheresis Awareness Day! | BioLineRx
BioLineRx on LinkedIn: BioLineRx is proud to announce U.S. FDA ...
BioLineRx on LinkedIn: #jpm2024 #fiercejpmweek
#tandem24 | BioLineRx
#multiplemyeloma | BioLineRx
BioLineRx | Modiin, Israel
#asfa | BioLineRx
BioLineRx | Learn About BioLineRx
BioLineRx Receives Orphan Drug Designation for Novel Stem Cell ...
BioLineRx Ltd. - AnnualReports.com
Logo de BioLineRx aux formats PNG transparent et SVG vectorisé
BioLineRx - Alchetron, The Free Social Encyclopedia
BioLineRx | F6S
FDA Approves BioLineRx Drug for Multiple Myeloma – ISPE Boston
BioLineRx - Company Profile, Photos, and Jobs on Project Casting - 8421
BioLineRx Ltd. - ROE
What are the Porter's Five Forces of BioLineRx Ltd. (BLRX ...
BioLineRx Ltd. (BLRX) ANSOFF Matrix Analysis – DCFmodeling.com
Irit Gliko-Kabir - VP, Clinical Operations at BioLineRx | The Org
BioLineRx Announces Regulatory Submission of Phase 3 Registrational ...
BLRX - Biolinerx Latest Stock News & Market Updates
BioLineRx (BLRX) Stock Surges Over 50% Premarket, Here’s Why ...
BLRX | BioLineRX Ltd Stock Data, Price & News
We’re proud to announce FDA Approval of an innovative treatment to ...
We are excited to bring innovation to patients with multiple myeloma ...
BioLineRX’s BL-7010 Treatment of Celiac Disease and Gluten Sensitivity ...
BioLineRx: Weighing Aphexda's Breakthrough Against Financial Challenges ...
BioLineRx社の末梢血への造血幹細胞誘導薬Aphexdaを米国FDAが承認 | せいみ屋
BioLineRx: Advancing Oncology Solutions | PDF | Hematopoietic Stem Cell ...
快讯 | BioLineRx多发性骨髓瘤环肽新药获FDA批准上市 - 知乎
BioLineRx’s Aphexda approved to aid stem cell transplants for multiple ...
BioLineRx's Motixafortide Combination Therapy: A Paradigm Shift in ...
BioLineRx's Q1 2025: Unpacking Contradictions in Cash Runway ...
BLRX: Cast Off the Bowlines: Aphexda Commercialization
#fdaapproval #aphexda #medicalinnovation #multiplemyeloma #biolinerx ...
BioLineRx's Pancreatic Cancer Breakthrough: Motixafortide's PFS Data ...
BLRX Stock Price and Chart — NASDAQ:BLRX — TradingView
BioLineRx's proof-of-concept study is an initial step towards the goal ...
Companies Financial Statements
帮助收集干细胞！APHEXDA获批用于多发性骨髓瘤ASCT干细胞动员 - 知乎
Portfolio | Giza Venture Capital
For Immediate Release
BioLineRx, CTTQ To Commercialize Hepatitis C Drug, BL-8030, In China ...
Aphexda-Aphexda中文说明书,价格,哪里有卖-香港济民药业
Israeli Tech and Innovation News - NoCamels
